Related references
Note: Only part of the references are listed.Assessment of the Potential Diagnostic Value of Serum p53 Antibody for Cancer: A Meta-Analysis
Jun Zhang et al.
PLOS ONE (2014)
Usefulness of Serum Anti-p53 Antibody Assay for Lung Cancer Diagnosis
Yongjung Park et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients
De-Hai Yu et al.
CLINICA CHIMICA ACTA (2011)
Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer
Maha Hashim et al.
MEDICAL ONCOLOGY (2011)
Prognostic implications of circulating anti-p53 antibodies in lung cancer - a review
S. Kumar et al.
EUROPEAN JOURNAL OF CANCER CARE (2009)
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small-cell lung cancer
Ming-Sound Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters
RJ Gao et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: An alternative pathway to non-small-cell lung cancer
YC Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival -: art. no. 66
M Bergqvist et al.
BMC CANCER (2004)
Serum p53 antibodies in patients affected with ulcerative colitis
M Cioffi et al.
INFLAMMATORY BOWEL DISEASES (2004)
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-x(L) in resected non-small-cell lung cancers
AM Groeger et al.
HISTOPATHOLOGY (2004)
The presence of anti-p53 antibodies in sera prior to thoracic surgery in non small cell lung cancer patients:: Its implications on tumor volume, nodal involvement, and survival
M Bergqvist et al.
NEOPLASIA (2003)
Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking
S Sangrajrang et al.
LUNG CANCER (2003)
Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases
M Neri et al.
LUNG CANCER (2003)
Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers
M Cioffi et al.
LUNG CANCER (2001)
Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer
J Laudanski et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies
M Huncharek et al.
CANCER LETTERS (2000)
Share Paper
